Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Jonas Daniel S	2. Issuer Name and Ticker or Trading Symbol CONMED Corp [ CNMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP Legal Affairs,Gen. Counsel
(Last) (First) (Middle) C/O CONMED CORP, 11311 CONCEPT BOULEVARD	3. Date of Earliest Transaction (MM/DD/YYYY) 4/30/2021
(Street) LARGO, FL 33773 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	4/30/2021		M		700	A	$41.93	14506	D
Common Stock	4/30/2021		S		600	D	$142.581 ⁽¹⁾	13906	D
Common Stock	4/30/2021		S		100	D	$143.30	13806	D
Common Stock	4/30/2021		M		10000	A	$41.93	23806	D
Common Stock	4/30/2021		S		10000	D	$141.075 ⁽²⁾	13806	D
Common Stock	4/30/2021		M		5000	A	$59.96	18806	D
Common Stock	4/30/2021		S		5000	D	$142.00	13806	D
Common Stock	5/3/2021		M		4176	A	$41.93	17982	D
Common Stock	5/3/2021		S		4176	D	$145.5906 ⁽³⁾	13806	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Options To Purchase Common Stock	$41.93	4/30/2021		M			700	⁽⁴⁾	3/1/2027	Common Stock	700	$0	19176	D
Options To Purchase Common Stock	$41.93	4/30/2021		M			10000	⁽⁴⁾	3/1/2027	Common Stock	10000	$0	9176	D
Options To Purchase Common Stock	$59.96	4/30/2021		M			5000	⁽⁴⁾	3/1/2028	Common Stock	5000	$0	22000	D
Options To Purchase Common Stock	$41.93	5/3/2021		M			4176	⁽⁴⁾	3/1/2027	Common Stock	4176	$0	5000	D

Explanation of Responses:
(1)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.10 to $142.725. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
(2)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.00 to $141.17. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
(3)	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.52 to $145.61. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
(4)	The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Jonas Daniel S C/O CONMED CORP 11311 CONCEPT BOULEVARD LARGO, FL 33773			EVP Legal Affairs,Gen. Counsel